Please use this identifier to cite or link to this item:
https://dora.health.qld.gov.au/qldresearchjspui/handle/1/339
Title: | Sex-specific versus overall cut points for a high sensitivity troponin I assay in predicting 1-year outcomes in emergency patients presenting with chest pain | Authors: | Berndt, Sara L. Greenslade, Jaimi H. Ryan, Kimberley Than, Martin Body, R. Ho, Ariel Cullen, Louise Parsonage, William A. Carlton, Edward W. Pickering, John W. Greaves, Kim |
Issue Date: | 2016 | Source: | 102, (2), 2016, p. 120-126 | Pages: | 120-126 | Journal: | Heart | Abstract: | Objective: To evaluate the incidence of major adverse cardiac events (MACE) at 1 year in emergency department (ED) patients with possible acute coronary syndromes, stratified by high sensitivity troponin (hs-cTnI) concentrations using sex-specific cut points compared with overall cut points.Methods: In a multicentre observational study of 2841 patients, presentation hs-cTnI concentrations were categorised using sex-specific (women 16 ng/L; men 34 ng/L) and overall (26 ng/L) cut points. The primary outcome was MACE occurring within 1 year of presentation. Patients with hs-cTnI values concentrations within these categories were reported by sex and 1-year MACE. Net reclassification improvement (NRI) was computed to measure the change in prediction after altering the hs-cTnI cut points, and was calculated separately for events and non-events.Results: Application of sex-specific 99th percentile cut points rather than the overall cut point of 26 ng/L, reclassified 25 females from having a non-elevated troponin to having an elevated troponin, and 29 males from having an elevated troponin value to having a non-elevated troponin value on presentation. Of these, 7 (28.0%) females and 12 (41.4%) males had a 1-year MACE. There was no reclassification improvement for those with or without 1-year MACE (NRIevents=-1.5%, 95% CI -4.0% to 1.1%; NRInon-events -0.04%, 95% CI -0.5% to 0.4%).Conclusions: Sex-specific cut points improve the identification of women but not men at risk for 1-year MACE. The net-effect across the whole ED population with possible cardiac chest pain is minimal. Lowering the clinical cut point for both sexes may be appropriate for prognostic purposes.Trial Registration Number: ISRCTN No. 21109279, ACTRN12609000283279.Blind Peer Reviewed; Europe; Expert Peer Reviewed; Peer Reviewed; UK & Ireland. Instrumentation: Clinical Decision Making in Nursing Scale (CDMNS) (Jenkins). NLM UID: 9602087.PMID: 26729608. | DOI: | 10.1136/heartjnl-2015-308506 798 |
Resources: | http://search.ebscohost.com/login.aspx?direct=true&AuthType=ip,athens&db=ccm&AN=112763612&site=ehost-live | Keywords: | Acute Coronary Syndrome -- MortalityAcute Coronary Syndrome -- Blood;Chest Pain -- Diagnosis;Acute Coronary Syndrome -- Diagnosis;Chest Pain -- Etiology;Chest Pain -- Blood;Troponin -- Blood;Acute Coronary Syndrome -- Complications;Chest Pain -- Therapy;Emergency Service -- Statistics and Numerical Data;Hospitalization -- Statistics and Numerical Data;ROC Curve;Prognosis;Predictive Value of Tests;Outcome Assessment;Australia;Incidence;Female;Aged;Mortality;Sex Factors;Middle Age;Male;Human;Adult;Validation Studies;Comparative Studies;Evaluation Research;Multicenter Studies;Scales | Type: | Article |
Appears in Sites: | Sunshine Coast HHS Publications |
Show full item record
Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.